SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-116545
Filing Date
2022-11-09
Accepted
2022-11-09 16:59:44
Documents
13
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2230118d2_8k.htm   iXBRL 8-K 32660
2 EXHIBIT 99.1 tm2230118d2_ex99-1.htm EX-99.1 53471
  Complete submission text file 0001104659-22-116545.txt   276940

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA anip-20221109.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20221109_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20221109_pre.xml EX-101.PRE 22615
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2230118d2_8k_htm.xml XML 3464
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 221373505
SIC: 2834 Pharmaceutical Preparations